Birac
India's bioeconomy at $150 billion, innovation crucial for growth: BIRAC MD
India's biotechnology sector is witnessing remarkable growth, with the country's bioeconomy now valued at USD 150 billion but there is still significant untapped potential in innovation and product development, which could further elevate India's global standing in the sector, Dr Jitendra Kumar, Managing Director of the government's Biotechnology Industry Research Assistance Council (BIRAC), said. BIRAC is a not-for-profit public sector enterprise set up by the Department of Biotechnology (DBT) under the government that supports and promotes innovation, entrepreneurship, and research in the sector. In an interview with PTI, Kumar highlighted India's significant contributions to global healthcare, with 40 per cent of the world's generic medicines being supplied by Indian companies. "We have enormous potential and capability, but when it comes to the value of our bioeconomy, we are ranked 14th globally. This is because much of the value stems from patented, innovative products' -- an
 "India's bioeconomy at $150 billion, innovation crucial for growth: BIRAC MD")
Aurobindo Pharma ties up with BIRAC to develop coronavirus vaccine
Aurobindo Pharma on Tuesday announced collaboration with the Biotechnology Industry Research Assistance Council (BIRAC), set up by the Department of Biotechnology for the development of Covid vaccine
 "Aurobindo Pharma ties up with BIRAC to develop coronavirus vaccine")
Biotechnology start-ups get a boost with tax waiver on services from incubators
At present there are 10 approved incubators which support close to 300 start-ups
 "Biotechnology start-ups get a boost with tax waiver on services from incubators")
